ATE462438T1 - Verwendung von carrageenan zur behandlung von rhinovirus-infektionen - Google Patents

Verwendung von carrageenan zur behandlung von rhinovirus-infektionen

Info

Publication number: ATE462438T1
Authority: AT; Austria
Prior art keywords: carrageenan; rhinovirus infections; treat rhinovirus; treat; infections
Prior art date: 2006-12-05

Application number

AT07856354T

Other languages

English (en)

Inventor

Andreas Grassauer

Eva Prieschl-Grassauer

Christiane Meier

Alexander Pretsch

Original Assignee

Marinomed Biotechnologie Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-05

Filing date

2007-12-04

Publication date

2010-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39383268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE462438(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-05 Priority claimed from EP06450176A external-priority patent/EP1930015A1/de

2006-12-05 Priority claimed from US11/567,078 external-priority patent/US20080131454A1/en

2007-12-04 Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh

2010-04-15 Application granted granted Critical

2010-04-15 Publication of ATE462438T1 publication Critical patent/ATE462438T1/de

Links

241000709661 Enterovirus Species 0.000 title 1
229940113118 carrageenan Drugs 0.000 title 1
235000010418 carrageenan Nutrition 0.000 title 1
229920001525 carrageenan Polymers 0.000 title 1
239000000679 carrageenan Substances 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 title 1
206010061494 Rhinovirus infection Diseases 0.000 abstract 1
230000000840 anti-viral effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Dermatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Paper (AREA)

AT07856354T 2006-12-05 2007-12-04 Verwendung von carrageenan zur behandlung von rhinovirus-infektionen ATE462438T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06450176A EP1930015A1 (de)	2006-12-05	2006-12-05	Verwendung von Carrageenan zur Behandlung von Rhinovirus Infektionen
US11/567,078 US20080131454A1 (en)	2006-12-05	2006-12-05	Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
PCT/EP2007/010512 WO2008067982A2 (en)	2006-12-05	2007-12-04	Use of carrageenan for treating rhinovirus infections

Publications (1)

Publication Number	Publication Date
ATE462438T1 true ATE462438T1 (de)	2010-04-15

Family

ID=39383268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07856354T ATE462438T1 (de)	2006-12-05	2007-12-04	Verwendung von carrageenan zur behandlung von rhinovirus-infektionen

Country Status (23)

Country	Link
EP (1)	EP2101792B1 (de)
JP (1)	JP5470047B2 (de)
KR (1)	KR101437708B1 (de)
CN (1)	CN101678040B (de)
AT (1)	ATE462438T1 (de)
AU (1)	AU2007327934B2 (de)
BR (1)	BRPI0720054A2 (de)
CA (1)	CA2671317C (de)
CY (1)	CY1110658T1 (de)
DE (1)	DE602007005697D1 (de)
DK (1)	DK2101792T3 (de)
EA (1)	EA015930B1 (de)
ES (1)	ES2343701T3 (de)
IL (1)	IL198810A (de)
MA (1)	MA31145B1 (de)
MX (1)	MX2009005838A (de)
NO (1)	NO342681B1 (de)
NZ (1)	NZ577063A (de)
PL (1)	PL2101792T3 (de)
PT (1)	PT2101792E (de)
SI (1)	SI2101792T1 (de)
TN (1)	TN2009000211A1 (de)
WO (1)	WO2008067982A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2303287T3 (en) *	2008-07-01	2014-02-17	Marinomed Biotechnologie Gmbh	Antiallergic marine biopolymers
JP5702526B2 (ja)	2009-04-30	2015-04-15	Ｅｓファイバービジョンズ株式会社	抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
AU2010335594B2 (en)	2009-12-22	2015-05-21	Marinomed Biotechnologie Gmbh	Synergistic antiviral composition and use thereof
JP5900030B2 (ja)	2011-03-08	2016-04-06	凸版印刷株式会社	防湿容器
PT2898888T (pt) *	2014-01-22	2019-07-16	Visufarma B V	Composição que compreende iota-carragenina contra conjuntivite viral
AU2016293004B2 (en)	2015-07-14	2021-05-06	Unither Pharmaceuticals	Stuffy nose deblocking composition having antiviral activity
UA118192C2 (uk) *	2015-10-22	2018-12-10	Юрій Захарович Толчеєв	Противірусна фармацевтична композиція
KR102316819B1 (ko) *	2018-04-20	2021-10-25	한미약품 주식회사	카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
KR101995376B1 (ko) *	2018-08-20	2019-07-02	한미약품 주식회사	카라기난을 유효성분으로 포함하는 항-바이러스 조성물
GB2579600B (en)	2018-12-05	2023-07-05	Byotrol Plc	Anti-viral composition
CN111437270A (zh) *	2020-04-24	2020-07-24	瑞希(重庆)生物科技有限公司	一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法
JP7821168B2 (ja)	2020-09-08	2026-02-26	アルタミラメディカ，アーゲー	感染を防止するための組成物
KR102720037B1 (ko) *	2021-12-21	2024-10-22	(주)메디코어	비강 세정제 조성물 및 그 제조방법
EP4784132A1 (de)	2023-09-26	2026-08-05	MetrioPharm AG	5-amino-2,3-dihydro-1,4-phthalazindione zur behandlung von infektionen mit einem rna-virus
CN122270289A (zh) *	2023-11-30	2026-06-23	斯特拉斯堡大学	同时具有抗细菌和抗病毒特性的生物材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2263643T3 (es)	2000-07-28	2006-12-16	Immupharm Aps	Uso de hidroxietilrutosidos para el tratamiento de los sintomas del r esfriado comun, de la fiebre de heno y de infecciones relacionadas con el tacto respiratorio.
US6953483B2 (en) *	2002-03-05	2005-10-11	Litke Kenneth S	Aloe vera processed leather and leather gloves, garments, shoes and sandals made from aloe vera processed leather and a process for making aloe vera processed leather
AU2003245252A1 (en) *	2002-04-30	2003-11-17	Fmc Corporation	Carrageenan based antimicrobial compositions
CN1194981C (zh) *	2002-07-22	2005-03-30	青岛海洋大学	卡拉胶低聚糖的制备方法
CN100435805C (zh) *	2003-05-26	2008-11-26	福州大学	多糖硫酸酯作为制备抗流感病毒药物的应用
US20050009782A1 (en) *	2003-07-09	2005-01-13	Comper Wayne D.	Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
WO2006003521A1 (en) *	2004-02-06	2006-01-12	Monash University	High dose, short interval use of sulfated polysaccharides for the treatment of infections
DE202005014019U1 (de) *	2005-09-05	2005-11-24	G. Pohl-Boskamp Gmbh & Co. Kg	Zubereitung zum Ersatz von Speichelflüssigkeit und zur Pflege bei Trockenheit der Mund- und Rachenschleimhäute
ITRM20060115A1 (it) *	2006-03-06	2006-06-05	Paolo Ottier	Guanto costituito da tre strati sovrapposti di poliuretano di cui due a tenuta stagna contenenti olio lubrificante per la parpazione del seno femminile
DE102006031812A1 (de)	2006-07-07	2008-01-17	Leoni Ag	Sensorsystem und Sensorelement

2007
- 2007-12-04 SI SI200730256T patent/SI2101792T1/sl unknown
- 2007-12-04 CN CN2007800448779A patent/CN101678040B/zh active Active
- 2007-12-04 BR BRPI0720054-4A patent/BRPI0720054A2/pt not_active Application Discontinuation
- 2007-12-04 NZ NZ577063A patent/NZ577063A/en unknown
- 2007-12-04 KR KR1020097010412A patent/KR101437708B1/ko active Active
- 2007-12-04 MX MX2009005838A patent/MX2009005838A/es active IP Right Grant
- 2007-12-04 AT AT07856354T patent/ATE462438T1/de active
- 2007-12-04 ES ES07856354T patent/ES2343701T3/es active Active
- 2007-12-04 DK DK07856354.1T patent/DK2101792T3/da active
- 2007-12-04 EA EA200970529A patent/EA015930B1/ru not_active IP Right Cessation
- 2007-12-04 AU AU2007327934A patent/AU2007327934B2/en active Active
- 2007-12-04 JP JP2009539654A patent/JP5470047B2/ja active Active
- 2007-12-04 EP EP07856354A patent/EP2101792B1/de active Active
- 2007-12-04 DE DE602007005697T patent/DE602007005697D1/de active Active
- 2007-12-04 PT PT07856354T patent/PT2101792E/pt unknown
- 2007-12-04 WO PCT/EP2007/010512 patent/WO2008067982A2/en not_active Ceased
- 2007-12-04 CA CA2671317A patent/CA2671317C/en active Active
- 2007-12-04 PL PL07856354T patent/PL2101792T3/pl unknown
2009
- 2009-05-19 IL IL198810A patent/IL198810A/en active IP Right Grant
- 2009-05-20 NO NO20091955A patent/NO342681B1/no unknown
- 2009-05-29 TN TNP2009000211A patent/TN2009000211A1/fr unknown
- 2009-07-02 MA MA32065A patent/MA31145B1/fr unknown
2010
- 2010-06-25 CY CY20101100586T patent/CY1110658T1/el unknown

Also Published As

Publication number	Publication date
NO20091955L (no)	2009-09-04
SI2101792T1 (sl)	2010-08-31
DK2101792T3 (da)	2010-07-26
MA31145B1 (fr)	2010-02-01
IL198810A (en)	2013-03-24
CA2671317C (en)	2015-03-17
NO342681B1 (no)	2018-07-02
EP2101792A2 (de)	2009-09-23
CY1110658T1 (el)	2015-06-10
WO2008067982A3 (en)	2009-04-16
CN101678040B (zh)	2012-10-03
MX2009005838A (es)	2009-06-16
PL2101792T3 (pl)	2010-11-30
NZ577063A (en)	2011-05-27
HK1141980A1 (en)	2010-11-26
DE602007005697D1 (de)	2010-05-12
KR20090096598A (ko)	2009-09-11
WO2008067982A2 (en)	2008-06-12
BRPI0720054A2 (pt)	2013-12-17
CN101678040A (zh)	2010-03-24
TN2009000211A1 (en)	2010-10-18
KR101437708B1 (ko)	2014-09-03
EA200970529A1 (ru)	2009-12-30
AU2007327934B2 (en)	2013-04-18
EA015930B1 (ru)	2011-12-30
IL198810A0 (en)	2010-02-17
ES2343701T3 (es)	2010-08-06
JP5470047B2 (ja)	2014-04-16
EP2101792B1 (de)	2010-03-31
CA2671317A1 (en)	2008-06-12
PT2101792E (pt)	2010-06-25
AU2007327934A1 (en)	2008-06-12
JP2010512307A (ja)	2010-04-22

Legal Events

Date

Code

Title

Description

2010-10-15

UEP

Publication of translation of european patent specification

Ref document number: 2101792

Country of ref document: EP

Publication	Publication Date	Title
DE602007005697D1 (de)	2010-05-12	Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
EP2081593A4 (de)	2010-12-08	Bakterielle lebendimpfstoffe zur prophylaxe oder behandlung von virusinfektionen
BR112012010270A2 (pt)	2016-11-29	mentisulfonilmetano (msm) para tratamento de micro-organismos resistentes a fármaco
EA201100505A1 (ru)	2011-10-31	Органические соединения для применения для лечения бактериальных инфекций
EA200900023A1 (ru)	2009-06-30	Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли
EP2135858A4 (de)	2012-02-08	Zusammensetzung zur behandlung von infektionserkrankungen
IN2012DN00869A (de)	2015-07-10
EA200801580A1 (ru)	2009-02-27	Новые производные пирониндола и способ их получения
EA201101477A1 (ru)	2012-05-30	Органические соединения и их применение
EA201690265A3 (ru)	2016-10-31	Фармацевтические композиции, содержащие замещенные ациланилиды
UA107183C2 (uk)	2014-12-10	Феніламіно-ізонікотинамідні сполуки, їх застосування, фармацевтична композиція, що їх містить, та спосіб лікування гіперпроліферативних захворювань
ATE534391T1 (de)	2011-12-15	3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
CY1114760T1 (el)	2016-12-14	Θεραπευτικη αγωγη αθηροσκληρωσης
ME00582A (en)	2011-12-20	Tricyclic compound and pharmaceutical use thereof
EP1905452A4 (de)	2012-02-15	Wirkstoff zur prävention oder behandlung von glaukomen
ATE475424T1 (de)	2010-08-15	Cellulosesulfat zur behandlung von rhinovirus- infektionen
ATE532787T1 (de)	2011-11-15	Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus
ATE474574T1 (de)	2010-08-15	Imidazoazephinonverbindungen
UA94781C2 (ru)	2011-06-10	Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
ATE380188T1 (de)	2007-12-15	Substituierte chinolone
EA200702336A1 (ru)	2008-04-28	ПРИМЕНЕНИЕ 24-норУДХК
EA201000063A1 (ru)	2010-06-30	Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
ATE495186T1 (de)	2011-01-15	Antibakterielle amid-makrozyklen iv
DE602006012313D1 (de)	2010-04-01	Kombination aus pyrimidylaminobenzamid-verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen
ATE456949T1 (de)	2010-02-15	Verwendung von bupropionmetaboliten zur behandlung von entzündungserkrankungen